Experts predict weakness in Nifty, Bank Nifty

Since there is no relief coming on the Covid front and the US markets have also ended in red zone yesterday, market is expected to trade in 14,150 to 14,500 range.

Speaking on the expected market trend today Avinash Gorakshkar, Head of Research at Prifitmart Securities said, “Market is expected to remain weak as there is still no relief coming on the second wave of Covid-19 fears.

Gorakshkar said that one should continue focus on pharma, IT and FMCG stocks and advised investors to look at Aurobindo Pharma, Gland Pharma and Pfizer stocks as potential shares to buy today.

Shetti went on to add that the fear of sharp sell on rise is still persisting until 14,560 levels is surpassed decisively on the upside.

Despite positive opening, SGX Nifty failed to sustain the opening bell gains and finally slipped in the red zone.

…Read the full story